[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Insmed, Inc. Graphic](https://lunarcrush.com/gi/w:26/t:$insm.png) Insmed, Inc. (INSM)

Insmed, Inc. (INSM) is soaring due to positive clinical trial results and analyst upgrades. Social media is buzzing about the stock's all-time high.

### About Insmed, Inc.
Insmed, Inc. (INSM) is a biotechnology company developing treatments for serious pulmonary diseases.  
Insmed, Inc. uses the ticker $INSM for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$insm/insights)
- Insmed, Inc. (INSM) trading volume is up XXXXXX% from the previous year.
- Insmed, Inc. (INSM) social dominance is up XXXXX% from the previous week.

### Price: $XXXXXX [#](/topic/$insm/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$insm/time-series/close.tsv)  
The stock price is experiencing a strong uptrend, supported by positive clinical trial results, analyst upgrades, and high social media engagement, which is reflected in the current price of $104.70, a 1-year high.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| -XXXX%  | XXX%  | XXXX%  |

**1-Year High**: $XXXXXX on 2025-06-24  
**1-Year Low**: $XXXXX on 2025-04-10  
  
  
### AltRank: XXXXX [#](/topic/$insm/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$insm/time-series/alt_rank.tsv)  
Insmed, Inc. (INSM) is currently AltRank #1,552 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXXXX +896  
**1 Month**: XXXXX +84  
**6 Months**: XXXXX +1,385  
**1 Year**: XXXXX +990  
**1-Year High**: XXXXX on 2025-05-06  
**1-Year Low**: XX on 2025-06-10  
  
  
### Galaxy Score: XXXXX [#](/topic/$insm/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$insm/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX +2  
**6 Months**: XX -XX  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-05-15  
**1-Year Low**: XX on 2024-07-20  
  
  
### Engagements: XXXXX [#](/topic/$insm/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$insm/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX -XX%  
**1 Month**: XXXXXXX -XXXX%  
**6 Months**: XXXXXXXXX +18%  
**1 Year**: XXXXXXXXX +31%  
**1-Year High**: XXXXXXX on 2025-06-10  
**1-Year Low**: XXX on 2024-12-27  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XXX [#](/topic/$insm/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$insm/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +921%  
**6 Months**: XXXXX +200%  
**1 Year**: XXXXXX +233%  
**1-Year High**: XXXXX on 2025-07-07  
**1-Year Low**: XX on 2025-03-30  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XXX [#](/topic/$insm/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$insm/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Insmed, Inc. (INSM) in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +857%  
**6 Months**: XXXXX +361%  
**1 Year**: XXXXX +569%  
**1-Year High**: XXX on 2025-07-07  
**1-Year Low**: XX on 2025-03-30  

The most influential creators that mention Insmed, Inc. in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@BannerView](/creator/twitter/BannerView)       | X    | XXXXX     | X     | XXXXX       |
| [@next_gen66](/creator/twitter/next_gen66)       | X    | XXXXX     | X     | XXX         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$insm/100)
  
  
### Sentiment: XX% [#](/topic/$insm/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$insm/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +3%  
**6 Months**: XX% -X%  
**1 Year**: XX% +23%  
**1-Year High**: XXX% on 2024-07-27  
**1-Year Low**: XX% on 2025-03-03  

**Most Supportive Themes**
- **Analyst activity:** (45%) Analysts are increasing their positions in INSM, reflecting confidence.
- **Clinical trial success:** (35%) Positive trial data for brensocatib in treating fibrosis bronchiectasis is driving interest.
- **Positive social media engagement:** (15%) Increased social media engagements from influential accounts are fueling positive attention.
  
**Most Critical Themes**
- **Competitive Landscape:** (5%)  Discussions of competitors may present challenges to Insmed, Inc.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$insm/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/$insm/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXX%  
**1 Week**: XXXXX% +0.011%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% +0.0049%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2025-06-12  
**1-Year Low**: XXXXX% on 2025-03-30  
  
  
### Market Dominance: XXXXX% [#](/topic/$insm/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/$insm/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2025-05-14  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$insm/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$insm/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX +$4.60%  
**1 Month**: $XXXXXXXXXXXXXX +$3.30%  
**6 Months**: $XXXXXXXXXXXXXX +$50%  
**1 Year**: $XXXXXXXXXXXXXX +$59%  
**1-Year High**: $XXXXXXXXXXXXXX on 2025-06-24  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-01-10  

**Top assets mentioned**
In the posts about Insmed, Inc. in the last XX hours

[Bitcoin Incognito (XBI)](/topic/$xbi)
[Progressive Corp (PGR)](/topic/$pgr)
[Eli Lilly and Company (LLY)](/topic/$lly)
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)
[Rocket Lab USA, Inc. Common Stock (RKLB)](/topic/$rklb)
[SuperRare (RARE)](/topic/$rare)
[Royal Caribbean Cruises Ltd (RCL)](/topic/$rcl)
[United Therapeutics, Corp. (UTHR)](/topic/$uthr)
[Tesla, Inc. (TSLA)](/topic/$tsla)

**Top topics mentioned**
In the posts about Insmed, Inc. in the last XX hours

[bmnr](/topic/bmnr), [hims](/topic/hims), [pep](/topic/pep), [hood](/topic/hood), [msft](/topic/msft), [wmt](/topic/wmt), [meta](/topic/meta), [amzn](/topic/amzn), [mstr](/topic/mstr), [crcl](/topic/crcl), [goog](/topic/goog), [abbv](/topic/abbv), [nvda](/topic/nvda), [nke](/topic/nke), [pltr](/topic/pltr), [hwm](/topic/hwm), [jpm](/topic/jpm), [stocks](/topic/stocks), [aapl meta](/topic/aapl-meta), [avgo](/topic/avgo), [$7240t](/topic/$7240t), [spx](/topic/spx), [$xbi](/topic/$xbi), [$vrna](/topic/$vrna), [psv](/topic/psv), [stocks healthcare](/topic/stocks-healthcare), [teva](/topic/teva), [$legn](/topic/$legn), [$clro](/topic/$clro), [asts](/topic/asts), [lun](/topic/lun), [ter](/topic/ter), [$lixt](/topic/$lixt), [op](/topic/op), [$pgr](/topic/$pgr), [alt](/topic/alt), [$lly](/topic/$lly), [qqq](/topic/qqq), [$bbio](/topic/$bbio), [$rklb](/topic/$rklb), [$ipsey](/topic/$ipsey), [skil](/topic/skil), [$wint](/topic/$wint), [$rare](/topic/$rare), [$rcl](/topic/$rcl), [$uthr](/topic/$uthr), [ndaq](/topic/ndaq), [pfe](/topic/pfe), [manat](/topic/manat), [jnj](/topic/jnj), [jbl](/topic/jbl), [$tsla](/topic/$tsla), [nxt](/topic/nxt), [$repl](/topic/$repl), [lmt](/topic/lmt), [srm](/topic/srm), [gme](/topic/gme), [$cbrl](/topic/$cbrl), [$hwm](/topic/$hwm), [stocks financial services](/topic/stocks-financial-services), [elf](/topic/elf), [$lqda](/topic/$lqda), [united therapeutics corp](/topic/united-therapeutics-corp), [googl](/topic/googl), [$mgx](/topic/$mgx), [$edit](/topic/$edit), [$goog](/topic/$goog), [$wksp](/topic/$wksp), [$tvtx](/topic/$tvtx), [$com](/topic/$com), [$nvts](/topic/$nvts), [sonn](/topic/sonn), [flr](/topic/flr), [$rgnx](/topic/$rgnx), [coins ai](/topic/coins-ai), [$meta](/topic/$meta), [$futu](/topic/$futu), [$mgnx](/topic/$mgnx), [vera](/topic/vera), [$oprx](/topic/$oprx), [$ctos](/topic/$ctos), [$jdzg](/topic/$jdzg), [$ibm](/topic/$ibm), [$crcl](/topic/$crcl), [te](/topic/te), [$pg](/topic/$pg), [$srpt](/topic/$srpt), [$alny](/topic/$alny), [$amd](/topic/$amd), [stx](/topic/stx), [balance sheet](/topic/balance-sheet), [$sngx](/topic/$sngx), [norwegian krone](/topic/norwegian-krone), [clsk](/topic/clsk), [$bglc](/topic/$bglc), [$alec](/topic/$alec), [$nvct](/topic/$nvct), [fubo](/topic/fubo), [$fubo](/topic/$fubo), [$aehr](/topic/$aehr)

### Top Social Posts [#](/topic/$insm/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"@paperhands91 $LQDA green today while $INSM and $UTHR red again Too bad OpEx pin won't allow it above $XX today. Likely will have to wait until next week"  
[@BannerView](/creator/x/BannerView) on [X](/post/tweet/1946244609480204328) 2025-07-18 16:24:09 UTC 4078 followers, XXX engagements


"🎈 He is a great stock investor. @GavinGavin188 I followed him and bought a few stocks and made $83500. $TSLA $OPEN $XXII $APP $NVDA $LLY $RCL $BSLK $FLUT $YHC $GITS $HOOD $INSM $MU $NVDA $CRM $VLCN $BMNR $AAPL $META $QCOM $XXII $LLY $NFLX"  
[@collins_gr31769](/creator/x/collins_gr31769) on [X](/post/tweet/1946224871278796958) 2025-07-18 15:05:43 UTC X followers, XX engagements


"🚀 He is a great stock investor. @GavinGavin188 I followed him and bought a few stocks and made $83500. $HIMS $QCOM $CRCL $MSTR $YHC $FLUT $INSM $NKE $NUWE $SFM $BGLC $BSLK $RGC $INSM $ABBV $CRM $CRCL $BGLC $BA $PEP $CLRO $COM $TSLA $LIXT"  
[@EmilyGay44358](/creator/x/EmilyGay44358) on [X](/post/tweet/1946218037436424542) 2025-07-18 14:38:33 UTC X followers, XX engagements


"Follow this person @amhaack77 He has accumulated rich experience in stock trading. The stocks he recommended rose by more than 95%. My funds doubled. Very good $CZR $FAAS $BULL $AMC $EVOK $SCAG $INSM $MATH $INTC $LICN $ASST $LYB $KGC $HOLO $HKPD $SNOA $ADSK $WCT 🌟 👍"  
[@qynsack1341249](/creator/x/qynsack1341249) on [X](/post/tweet/1946165941810635164) 2025-07-18 11:11:33 UTC X followers, X engagements